Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amplify Seymour Cannabis ETF (NY: CNBS )

4.870 +0.240 (+5.18%)
Official Closing Price Updated: 6:30 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,171
Open 4.630
Bid (Size) 4.750 (1)
Ask (Size) 5.000 (3)
Prev. Close 4.630
Today's Range 4.630 - 4.870
52wk Range 3.380 - 6.480
Shares Outstanding 66,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These Two Cannabis Stocks Face Setback Following Pennsylvania Budget Approval: What You Need To Know
Pennsylvania's recent budget approval excludes the legalization of recreational cannabis, marking a significant setback for cannabis companies like Jushi Holdings (OTC: JUSHF) and TILT Holdings (OTC:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis

Performance

YTD
+15.68%
+15.68%
1 Month
+8.46%
+8.46%
3 Month
-2.85%
-2.85%
6 Month
+1.04%
+1.04%
1 Year
+29.28%
+29.28%

More News

Read More
The Canadian Cannabis Report - Monday, June 3
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, May 20
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, May, 6
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
The Canadian Cannabis Report - Monday, April 22
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Shine As Benzinga's Cannabis Capital Conference Unfolds
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadiab Cannabis Report - Monday, April 8
Via Talk Markets
Topics Cannabis
Exposures Cannabis
There Is No Comparison Between These 9 Cannabis ETFs
Via Talk Markets
Topics Cannabis ETFs
Exposures Cannabis
The Canadian Cannabis Report - Monday, March 25
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, March 11
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, March 18
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, March 4
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Feb. 26
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Feb. 19
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Fen. 12
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Feb. 5
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Jan. 29
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Jan. 22
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
The Canadian Cannabis Report- Monday, Jan. 15
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Jan. 8
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Jan. 1
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Dec. 18
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.